About us
Mission & Vision
Governance
Facility
Research products
Viral vector services
Viral vector products
Design my vector
GMP Services
GMP Manufacturing
Fill & Finish
Technologies
LentiCare®
FlashRNA®
Other technologies
Resources
News & Events
Case Studies
Resources
Blog
Careers
Contact us
Search
Home
»
Primary cells and in vivo immunomodulation using LentiFlash®, a chimeric RNA delivery technology designed for clinical applications
Back
04.08.2019
Share on it:
Previous article
Next article
